Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-03

Clinical Trial Update: Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating botulinum toxin type A for male chronic prostatitis/chronic pelvic pain syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Daniel Stephan Engeler | Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Prostatitis | Phase 3 | Status: TERMINATED